Pipeline Molecules

At Genentech BioOncology, we are on the cutting edge of cancer research, as evidenced by our robust product pipeline of innovative molecules designed to target cancer through specific molecular processes.

Select any of the pipeline molecules below to learn more:

Akt Inhibitor (GDC-0068)
Anti-EGFL7
Bcl-2-Specific Inhibitor (GDC-0199)
MEK Inhibitor (GDC-0973)
Navitoclax
Obinutuzumab (GA101)
Onartuzumab (MetMAb)
PI3K Inhibitor (GDC-0941)
PI3K/mTOR Inhibitor (GDC-0980)
Trastuzumab emtansine (T-DM1)